Kuros Biosciences ^Company

Kuros Biosciences is a Swiss-based company that specializes in developing innovative products for tissue repair and regeneration. The company was founded in 2000 as a spin-off of the Eidgen\xf6ssische Technische Hochschule Z\xfcrich (ETHZ) and has developed a pipeline of products based on its proprietary technology platforms. Kuros has acquired Xpand Biotechnology to gain access to its MagnetOs family of bone graft substitutes and the associated surface science technology. The company has one product that has marketing approval in the EU and US, with further products expected to achieve EU approval this year. Kuros has a pipeline of clinical stage programs in various stages of development and has enrolled over 600 patients in multinational clinical trials. The company's mission is to discover, develop and deliver innovative fusion technologies that prevent non-unions.